Nephrotoxic effects of designer drugs: synthetic is not better!

@article{Luciano2014NephrotoxicEO,
  title={Nephrotoxic effects of designer drugs: synthetic is not better!},
  author={Randy L. Luciano and Mark A Perazella},
  journal={Nature Reviews Nephrology},
  year={2014},
  volume={10},
  pages={314-324}
}
Designer drugs are synthetic, psychoactive substances with similar structures and activity to existing scheduled drugs or controlled chemical compounds. The use of these drugs is not generally considered illegal and they cannot be detected using standard toxicology tests—essentially they are considered to be 'legal highs'. Over the past several years, increasing numbers of designer drugs have become available. These drugs are classified as amphetamine derivatives, phenylpiperazine derivatives… 
Nephrotoxicity of Combining 2-Phenethylamine and N, N-Dimethyl-β-Phenethylamine
TLDR
This work investigated the possible nephrotoxic effects of two naturally occurring compounds: 2-phenethylamine and N, N-dimethyl-β-phenthylamine alone and in combination because they are currently used in dietary supplements presently on the market.
Fatal Poisonings Associated with New Psychoactive Substances.
This chapter describes how new psychoactive substances (NPS) have been involved in fatal intoxications from 2010 and onwards. It summarizes the circumstances, antemortem symptoms, and adverse effects
The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines
TLDR
The acute and chronic toxicity of many NPSs is unknown or very sparsely investigated, and there is a need for evidence-based-treatment recommendations for acute intoxications and a demand for new strategies to analyze these compounds in clinical and forensic cases.
New Drugs of Abuse and Withdrawal Syndromes.
Novel psychoactive substances of interest for psychiatry
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine‐like
Pharmacology behind Common Drug Nephrotoxicities.
  • M. Perazella
  • Medicine, Biology
    Clinical journal of the American Society of Nephrology : CJASN
  • 2018
TLDR
Clinically relevant aspects of drug-induced nephrotoxicity for the clinical nephrologist are reviewed.
The nephrologist's guide to cannabis and cannabinoids
  • J. Rein
  • Medicine, Biology
    Current opinion in nephrology and hypertension
  • 2020
TLDR
Patients and healthcare professionals have little guidance or evidence regarding the impact of cannabis use on people with kidney disease and this knowledge gap will remain as long as federal regulations remain prohibitively restrictive towards prospective research.
Systematic review of nephrotoxicity of drugs of abuse, 2005–2016
TLDR
A wide range of renal manifestations were found to be associated with drug abuse, which will put a significant percentage of the population at an elevated risk for poor renal outcomes.
Acute and delayed nephropathy due to methamphetamine abuse
TLDR
The effects of methamphetamine on the kidneys can be divided into the following sub-groups: vascular effects, non-traumatic rhabdomyolysis and direct nephrotoxicity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 136 REFERENCES
AKI associated with synthetic cannabinoids: a case series.
TLDR
The close temporal and geographic associations between the clinical presentation and the development of AKI strongly suggest an association between these SPICE preparations and AKI, especially in young adults with negative urine drug screens.
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
TLDR
The first (to the authors' knowledge) cases of myocardial infarction after smoking K2 are reported, and public education and awareness need to be heightened about the possible health implications of K2.
Designer drugs: a medicinal chemistry perspective
TLDR
This review describes how clandestine chemists used the principles of medicinal chemistry to design molecules that elicit the effects of opioids, amphetamine and analogs, cannabinoids, and phencyclidine analogs while circumventing the law.
Nephrotoxicity of recreational party drugs
N‐benzylpiperazine (BZP) is the active ingredient in recreational ‘party’ pills with a stimulant, euphoric mechanism of action akin to that of 3,4‐methylenedioxymethamphetamine (MDMA or ecstasy).
Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012
TLDR
The results of the investigation determined that no single SC brand or compound explained all 16 cases, and public health practitioners, poison center staff members, and clinicians should be aware of the potential for renal or other unusual toxicities in users of SC products and should ask about SC use in cases of unexplained AKI.
Synthetic cannabinoid use associated with acute kidney injury*
TLDR
A previously healthy 26-year-old male presented to the emergency department with one day of abdominal pain, nausea, vomiting and lower back pain and was discharged after six days in the hospital with AKI of unknown etiology and serum creatinine of 3.09 mg/dL.
Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management.
TLDR
An overview of MDMA pharmacology and acute toxicity will be given followed by a plan for clinical management of patients with acute MDMA toxicity.
Bath salt intoxication causing acute kidney injury requiring hemodialysis
TLDR
Traditional bath salts contain a combination of inorganic salts like Epsom salts, table salt, baking soda, sodium metaphosphate, and borax that have cleansing properties and act as central nervous system stimulants with high additive and abuse potential.
...
1
2
3
4
5
...